🇺🇸 FDA

Company profile · Sponsor

Guerbet

ED5EBD1 · EMA pharma EU
Pipeline
4
Drugs
0
Patents
0

Quick answer

Guerbet (ED5EBD1) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker ED5EBD1
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (4)

Search pipeline →

  1. DOTAREM 0,5 mmol/mL, solution injectable, GADOPICLENOL

    Guerbet

    Suspected Vascular Disease of supra-aortic (carotid/vertebrobasilar), peripheral or abdominal/renal arteries

    phase 3 small molecule active

    1 trial

  2. Dotarem®

    Guerbet

    Primary Brain Tumor

    approved small molecule completed

    1 trial

  3. Gadoterate meglumine

    Guerbet

    Hepatocellular Carcinoma

    approved small molecule terminated

    1 trial

  4. Gadoxetate disodium

    Guerbet

    Motor Function

    approved small molecule active

    1 trial

Frequently asked questions

What is Guerbet?

Guerbet (ED5EBD1) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Guerbet sponsor?

We track 4 ClinicalTrials.gov-linked programs for Guerbet, including DOTAREM 0,5 mmol/mL, solution injectable, GADOPICLENOL and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Guerbet company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.